The Infectious Diseases Society of America (IDSA) says it applauds President Obamas fiscal year (FY) 2012 budget, which makes needed strategic investments to strengthen key U.S. public health and research initiatives. The IDA released the following statement:
"The presidents budget will assist in further strengthening our nations capacity to prevent, diagnose, and treat an ever-increasing number of infectious diseases threats. Now, the Society calls upon Congress to endorse the presidents proposal and bolster funding for U.S. and global infectious diseases research and public health activities through the nations leading federal health agencies.
"The presidents budget proposal supports critically needed infectious diseases research at the National Institutes of Health (NIH), especially at the National Institute for Allergy and Infectious Diseases (NIAID). An analysis published just this month in the New England Journal of Medicine underscores the important benefits government-supported research has had in addressing infectious diseases threats and in improving public health [i]. This important research also drives economic development in communities across the country.
"Investments proposed for critical infectious diseases programs at the Centers for Disease Control and Prevention (CDC) will help strengthen surveillance and control programs to protect Americans from antibiotic-resistant bacterial infections, allow states to continue to screen for infections such as HIV and viral hepatitis, and allow more Americans to receive immunizations against many life-threatening diseases. We are disappointed, however, that the budget proposes a decrease in domestic tuberculosis (TB) funding at a time when multi-drug resistant TB (MDR-TB) remains a serious threat. Additionally, while the budget talks about strengthening CDCs antimicrobial resistance activities, a specific funding amount for the program is not specified. As CDC has said, antimicrobial resistance is one of the worlds most pressing clinical and public health problems; thus, it is essential that funding for this program be significantly increased.
"We need a strong Food and Drug Administration (FDA) to ensure that innovative infectious diseases products are evaluated and approved expeditiously. Such reviews require a highly skilled review staff that understands urgent clinical needs as well as a greater emphasis on regulatory science. With these critical needs in mind, the presidents budget properly invests in FDAs regulatory science and countermeasures initiative. These efforts will speed the approval of new medical countermeasures, including novel antimicrobial drugs, which are critically needed to respond to current and future infectious outbreaks.
"Finally, IDSA supports the $765 million proposed for the Biomedical Advanced Research and Development Authority (BARDA), including $100 million to create a strategic investment entity to provide financial and business support to companies that develop new antibiotics and other medical countermeasures. The proposed funding will ensure the availability of resources throughout the advanced stages of development and give needed flexibility for BARDA to partner effectively with industry.
"IDSA looks forward to working with the administration and Congress to move forward on this budget that invests wisely in the prevention, diagnosis, and treatment of life-threatening infectious diseases."
Dear Helpdesk: Working in a Toxic Health Care Environment
March 28th 2024Dear Helpdesk is your steadfast companion, offering life coaching and workplace advice from 2 seasoned IPs for some of your most challenging real-life situations. Let us help you navigate the intersection between work and life, guiding you to navigate the dynamic world of infection prevention with confidence and grace. This article is on handling a toxic health care environment.
Product Locator: Spring and Early Mother's Day Gift Guide for Infection Prevention Personnel
March 27th 2024Whether it's a spring holiday, birthdays, or no reason at all, infection prevention personnel love to give and receive gifts that help at the end of a stressful day. Infection Control Today® offers some gift ideas for infection prevention personnel and their families.
Catching Up With Vangie Dennis, AORN 2022-2023 President at AORN 2024
March 26th 2024Infection Control Today (ICT) had the privilege of catching up with Vangie Dennis, MSN, RN, CNOR, CMLSO, at the Association of periOperative Registered Nurses' (AORN’s) International Surgical Conference & Expo 2024. As the former president of AORN and an esteemed figure in perioperative services, Vangie Dennis shared insights into her recent endeavors and the exciting new chapter she's embarked upon.
How To Optimize Your Time Management Strategies for the Busy Infection Preventionist
March 25th 2024Is your calendar resembling a chaotic masterpiece of overlapping tasks? Join the club of infection preventionists striving to balance responsibilities. Dive into proven strategies from a fellow infection preventionist to reclaim control of your time, streamline tasks, and boost productivity effectively. This is an IP Lifeline article.